US Patent Issued to SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL on May 27 for "Anti-B7-H3 antibody, preparation method therefor, conjugate and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,406, issued on May 27, was assigned to SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL Co. LTD. (Shanghai).

"Anti-B7-H3 antibody, preparation method therefor, conjugate and application thereof" was invented by Qingsong Guo (Shanghai), Fang Wu (Shanghai), Tong Yang (Shanghai) and Yijun Shen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "An anti-B7-H3 antibody, a preparation method therefor, a conjugate and an application thereof. The anti-B7-H3 antibody comprises a complementarity determining region: one or more of heavy chain CDR1, heavy chain CDR2, and heavy chain CDR3, and/or one or more of light chain CDR1, light chain CDR2, and light chai...